Why the study?
Very high-power short-duration ablation reduces esophageal injury risk during pulmonary vein isolation but raises concerns about lesion durability in thicker atrial myocardium.
Does a hybrid approach combining very high-power short-duration and Ablation Index-guided ablation reduce procedural duration and maintain efficacy compared to conventional AI-guided PVI in patients with atrial fibrillation?
Does a hybrid approach combining very high-power short-duration and Ablation Index-guided ablation reduce procedural duration and maintain efficacy compared to conventional AI-guided PVI in patients with atrial fibrillation?
A hybrid ablation approach using very high-power short-duration settings reduces procedural time without compromising 1-year efficacy or safety in patients with atrial fibrillation.
May shorten PVI duration with similar 1-year AF freedom; leaves open confirmation in randomized trials.
Introduction A novel temperature‐controlled radiofrequency (RF) catheter enables pulmonary vein isolation (PVI) using very high‐power short‐duration (vHPSD) ablation, reducing esophageal injury risk but raising concerns about lesion durability in thicker atrial myocardium. This study aimed to assess the efficacy and safety of a hybrid approach that integrates conventional Ablation Index (AI)‐guided PVI with vHPSD ablation. Methods This prospective, single‐center study enrolled 160 consecutive patients with atrial fibrillation (AF) between January 2023 and December 2023, who were allocated into two groups. Group 1 ( n = 80) underwent conventional AI‐guided PVI using a 40 W setting, while Group 2 ( n = 80) received a hybrid approach combining 90 and 50 W ablation with a temperature‐controlled RF catheter (QDOT Micro, Biosense Webster Inc., Diamond Bar, CA). Results Group 2 demonstrated a significantly shorter duration for PVI compared to Group 1 (28 ± 11 min vs. 35 ± 10 min, p < 0.001), with similar rates of first pass isolation (86% vs. 89%, p = 0.63) and acute reconnection (10% vs. 5%, p = 0.23). Complication rates were comparable between the groups (1.3% vs. 1.3%, p = 1.00), with no cases of esophageal or phrenic nerve injury reported. Kaplan–Meier analysis showed no significant difference in freedom from AF at 1 year (84% vs. 83%, log‐rank p = 0.78). Conclusion The integration of Ablation Index‐guided ablation with vHPSD ablation, utilizing a novel temperature‐controlled RF catheter, significantly reduces procedural duration while maintaining safety and efficacy comparable to conventional AI‐guided PVI.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: